Shao Jing Tong
Director of Finance/CFO presso REMEGEN CO., LTD.
Profilo
Attualmente, Shaojing Tong ricopre la posizione di direttore finanziario presso InnoCare Pharma Ltd. Il signor Tong è anche nel consiglio di amministrazione di YishengBio Co. In precedenza il signor Tong ha occupato la posizione di direttore della ricerca globale presso la Bank of America Merrill Lynch (New York), analista di ricerca presso Mehta Partners LLC, direttore esecutivo della ricerca nel settore degli investimenti presso UBS (Cina) Ltd., analista di ricerca presso Merrill Lynch Far East Ltd. e analista presso UBS Securities (Asia) Ltd. Shaojing Tong ha conseguito un MBA presso la New York University, una laurea presso l'Università di Pittsburgh e una laurea presso la University of Science & Technology of China.
Posizioni attive di Shao Jing Tong
| Società | Posizione | Inizio |
|---|---|---|
| REMEGEN CO., LTD. | Director of Finance/CFO | 28/09/2023 |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Director/Board Member | - |
Precedenti posizioni note di Shao Jing Tong
| Società | Posizione | Fine |
|---|---|---|
| YS BIOPHARMA CO., LTD. | Director/Board Member | 29/02/2024 |
| INNOCARE PHARMA LIMITED | Director of Finance/CFO | 31/12/2022 |
UBS Securities (Asia) Ltd.
 UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Analyst-Equity | 31/05/2019 |
UBS (China) Ltd.
 UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Corporate Officer/Principal | 01/05/2019 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | 01/05/2013 |
Formazione di Shao Jing Tong
| University of Pittsburgh | Graduate Degree |
| New York University | Masters Business Admin |
| University of Science & Technology of China | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INNOCARE PHARMA LIMITED | Health Technology |
| REMEGEN CO., LTD. | Health Technology |
| YS BIOPHARMA CO., LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
Mehta Partners LLC
 Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | Finance |
Merrill Lynch Far East Ltd.
 Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Finance |
UBS Securities (Asia) Ltd.
UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Finance |
| Bank of America Merrill Lynch (New York) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
UBS (China) Ltd.
UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The private company is based in Beijing, China. | Finance |
- Borsa valori
- Insiders
- Shao Jing Tong
